A Study of SHR-A1909 in Subjects With Advanced Malignant Tumors
Clinical trial NCT05162469 · COMPLETED
Trial details
- NCT number
- NCT05162469
- Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-23
- Primary completion
- 2024-03-28
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.